Invention Grant
- Patent Title: Oral preparation of obeticholic acid
-
Application No.: US16089477Application Date: 2017-03-30
-
Publication No.: US11413295B2Publication Date: 2022-08-16
- Inventor: Mitsuhiro Matono , Tetsuya Hayama
- Applicant: Intercept Pharmaceuticals, Inc.
- Applicant Address: US NY New York
- Assignee: Intercept Pharmaceuticals, Inc.
- Current Assignee: Intercept Pharmaceuticals, Inc.
- Current Assignee Address: US NY New York
- Priority: JPJP2016-071404 20160331
- International Application: PCT/JP2017/013221 WO 20170330
- International Announcement: WO2017/170858 WO 20171005
- Main IPC: A61K31/575
- IPC: A61K31/575 ; A61K47/26 ; A61K47/32 ; A61K47/38 ; A61K9/20 ; A61K47/10 ; A61K47/36 ; A61K9/28 ; A61K9/14 ; A61K9/16
Abstract:
The present invention pertains to an oral preparation having exceptional elutability, the oral preparation containing obeticholic acid or a pharmacologically acceptable salt thereof, a water-soluble excipient, a disintegrating agent, and a water-soluble polymer binder, wherein the oral preparation is a quick-release tablet.
Public/Granted literature
- US20190216826A1 ORAL PREPARATION HAVING EXCEPTIONAL ELUTABILITY Public/Granted day:2019-07-18
Information query
